|
|
||
| Stakeholder(s) Opposed 1 | Drug companies, especially those in the import business, may oppose the proposed idea because such measures will affect their businesses and profits. They will oppose the proposed idea to keep the status quo. However, they need to consider the negative effects of the opioid epidemic as a public health issue. They should collaborate to prevent misuse of their drugs and ensure that it does not become a source of death and devastation for many families and individuals. | |
| Stakeholder(s) Opposed 2 | Users, especially those addicted to opioids, may oppose the proposed idea as it will reduce their uptake of drugs. Users at state level may also object these measures arguing the current actions and legislative efforts are sufficient to address the issue. However, it is essential for them to understand the magnitude of the problem and support the proposed idea. | |